Literature DB >> 15670635

Acute and chronic continuous methamphetamine have different long-term behavioral and neurochemical consequences.

Colin Davidson1, Tong H Lee, Everett H Ellinwood.   

Abstract

We compared two different methamphetamine dosing regimens and found distinct long-term behavioral and neurochemical changes. Adult rats were treated with 1-day methamphetamine injection (3x5 mg/kg s.c., 3 h apart) or 7-day methamphetamine minipump (20 mg/kg/day s.c.). The minipump regimen models the sustained methamphetamine plasma levels in some human bingers whereas the 1-day regimen models a naive user overdose. On withdrawal days 7 and 28, rats were acutely challenged with cocaine to test for behavioral sensitization and subsequently sacrificed for caudate and accumbens dopamine tissue content. Other rats were analyzed on withdrawal days 3, 7 or 28 using voltammetry in caudate slices. On withdrawal days 7 and 28, the methamphetamine injection but not the minipump rats showed behavioral cross-sensitization to cocaine. There was no change in baseline dopamine release, reuptake or sensitivity to quinpirole in any treatment group on either withdrawal day. However, consistent with the behavioral sensitization, cocaine had a greater effect in potentiating dopamine release and in blocking dopamine reuptake in methamphetamine injection versus saline irrespective of withdrawal day. The minipump group showed tolerance to the dopamine releasing effect of cocaine on withdrawal day 28 and had lower dopamine tissue content in the caudate versus the methamphetamine injection group. Dopamine turnover as measured by the DOPAC/dopamine ratio tended to be higher in the minipump-treated rats. These data suggest that the behavioral cross-sensitization seen in the methamphetamine injection rats could be in part due to the increased potency of cocaine in blocking dopamine reuptake and in increasing dopamine release. The decreased potency of cocaine in the caudate slices from the minipump-treated group may be related to decreased dopamine tissue content.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15670635     DOI: 10.1016/j.neuint.2004.11.004

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   4.297


  19 in total

1.  Repeated exposure to methamphetamine causes long-lasting presynaptic corticostriatal depression that is renormalized with drug readministration.

Authors:  Nigel S Bamford; Hui Zhang; John A Joyce; Christine A Scarlis; Whitney Hanan; Nan-Ping Wu; Véronique M André; Rachel Cohen; Carlos Cepeda; Michael S Levine; Erin Harleton; David Sulzer
Journal:  Neuron       Date:  2008-04-10       Impact factor: 17.173

2.  Cocaine and methamphetamine induce opposing changes in BOLD signal response in rats.

Authors:  Saeid Taheri; Zhu Xun; Ronald E See; Jane E Joseph; Carmela M Reichel
Journal:  Brain Res       Date:  2016-04-18       Impact factor: 3.252

3.  Effect of three different regimens of repeated methamphetamine on rats' cognitive performance.

Authors:  Seyedeh Masoumeh Seyedhosseini Tamijani; Elmira Beirami; Abolhassan Ahmadiani; Leila Dargahi
Journal:  Cogn Process       Date:  2017-09-25

4.  Spatial inhibition and the visual cortex: a magnetic resonance spectroscopy imaging study.

Authors:  R Salo; T E Nordahl; M H Buonocore; Y T Natsuaki; C D Moore; C Waters; M H Leamon
Journal:  Neuropsychologia       Date:  2011-01-13       Impact factor: 3.139

5.  PEGylation of a High-Affinity Anti-(+)Methamphetamine Single Chain Antibody Fragment Extends Functional Half-Life by Reducing Clearance.

Authors:  Emily E Reichard; Nisha Nanaware-Kharade; Guillermo A Gonzalez; Shraddha Thakkar; S Michael Owens; Eric C Peterson
Journal:  Pharm Res       Date:  2016-09-12       Impact factor: 4.200

6.  Effects of VMAT2 inhibitors lobeline and GZ-793A on methamphetamine-induced changes in dopamine release, metabolism and synthesis in vivo.

Authors:  Andrew C Meyer; Nichole M Neugebauer; Guangrong Zheng; Peter A Crooks; Linda P Dwoskin; Michael T Bardo
Journal:  J Neurochem       Date:  2013-08-20       Impact factor: 5.372

7.  Inhibition by oxytocin of methamphetamine-induced hyperactivity related to dopamine turnover in the mesolimbic region in mice.

Authors:  Jia Qi; Jing-Yu Yang; Ming Song; Yan Li; Fang Wang; Chun-Fu Wu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-19       Impact factor: 3.000

8.  Novelty-induced locomotion is positively associated with cocaine ingestion in adolescent rats; anxiety is correlated in adults.

Authors:  Q David Walker; Nicole L Schramm-Sapyta; Joseph M Caster; Samuel T Waller; Matthew P Brooks; Cynthia M Kuhn
Journal:  Pharmacol Biochem Behav       Date:  2008-08-28       Impact factor: 3.533

9.  Methamphetamine self-administration is associated with persistent biochemical alterations in striatal and cortical dopaminergic terminals in the rat.

Authors:  Irina N Krasnova; Zuzana Justinova; Bruce Ladenheim; Subramaniam Jayanthi; Michael T McCoy; Chanel Barnes; John E Warner; Steven R Goldberg; Jean Lud Cadet
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

10.  Human methamphetamine pharmacokinetics simulated in the rat: behavioral and neurochemical effects of a 72-h binge.

Authors:  Ronald Kuczenski; David S Segal; William P Melega; Goran Lacan; Stanley J McCunney
Journal:  Neuropsychopharmacology       Date:  2009-07-01       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.